<span>An American drug enterprise has devised a manner of producing insulin by way of recombinant DNA technologies. Insulin encompass 2 polypeptide chains (A and B) appropriate by way of disulphide bridges. The polypeptides are 'engineered' one after the other, and later further collectively to make lively insulin. The bacterium used is a stress of E. col </span> <span>It would be like taking a gold ring, breaking it open, and saudering to it a silver ring.</span>
